TBPH icon

Theravance Biopharma (TBPH)

NASDAQ

$16.01

$0.18 (

+1.14%

)

1D
5D
1M
6M
1Y
5Y
Market closed

TBPH: $16.01 / ₿ 0.0002 BTC / 23737 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$15.83
$7.90 - $21.03
$824.40M
5.76
$15.81
$508,782.48
51.49M
7.78
$6.96 - $16.71
$15.73 - $16.16
Yes

What is Theravance Biopharma (TBPH)?

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

The Theravance Biopharma (TBPH) stock price has been rising

The Theravance Biopharma, Inc. Ordinary Shares (TBPH) stock price today is $16.01, reflecting a +1.14% move since the market opened. The company’s market capitalization stands at $824.40M, with a daily trading volume of $508.78K shares. For investors tracking price trends, Theravance Biopharma, Inc. Ordinary Shares stock has ranged between $15.73 and $16.16 today. The previous closing price was $15.83.

Get started with Theravance Biopharma (TBPH)

Ready to get started? Follow the steps below, or read our guide on how to buy Theravance Biopharma stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy TBPH

Search for TBPH in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy TBPH.

TBPH FAQs

TBPH is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

TBPH is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Theravance Biopharma, Inc. Ordinary Shares (TBPH) has traded between a low of $7.90 and a high of $21.03.

TBPH is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Theravance Biopharma? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
TBPH icon
TBPH

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Theravance Biopharma in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

AIXI icon

AIXI

SKYQ icon
NVDA icon

NVDA

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

ARVLF icon

ARVLF

SDCCQ icon
YOTAR icon

YOTAR

APCXW icon
LPCN icon

LPCN

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.